Month: April 2021

Oklahoma and Appriss Health Announce First Year Outcomes on Integration of Prescription Drug Monitoring Program Data into Providers’ Electronic Workflows Advancing

OKLAHOMA CITY and LOUISVILLE, Ky., April 28, 2021 /PRNewswire/ -- Prescribers in Oklahoma have made more than 15.5 million patient queries...

Lutris Pharma Phase 1 Results of LUT014 for Skin Toxicities Associated with Treatment of Colorectal Cancer Patients with EGFR Inhibitors Published in Cancer Discovery

TEL AVIV, Israel, April 28, 2021 /PRNewswire/ -- Lutris Pharma, a clinical stage biopharmaceutical company focusing on improving anti-cancer therapies by...

error: Content is protected !!